Reuters
Search documents
Verisk quarterly profit beats estimates on steady data analytics demand
Reuters· 2026-02-18 12:56
Verisk quarterly profit beats estimates on steady data analytics demand | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Verisk logo is seen in this illustration taken November 9, 2025. REUTERS/Dado Ruvic/Illustration [Purchase Licensing Rights, opens new tab]Feb 18 (Reuters) - Verisk's [(VRSK.O), opens new tab] fourth-quarter profit topped Wall Street expectations on Wednesday on the back of steady demand for its data analytics off ...
Insulet beats quarterly estimates on strong demand for wearable insulin pumps
Reuters· 2026-02-18 12:55
Insulet beats quarterly estimates on strong demand for wearable insulin pumps | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Dexcom Inc]Follow[Insulet Corp]FollowFeb 18 (Reuters) - Insulet [(PODD.O), opens new tab] reported better-than-expected fourth-quarter results on Wednesday, on the back of strong demand for its tubeless insulin pumps that eliminate the need for daily injections.The medical device maker also forec ...
Charles River forecasts upbeat 2026 profit on improved demand for drug development services
Reuters· 2026-02-18 12:54
Charles River forecasts upbeat 2026 profit on improved demand for drug development services | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Charles River Laboratories International Inc]FollowFeb 18 (Reuters) - Contract drug developer Charles River Laboratories [(CRL.N), opens new tab] on Wednesday forecast annual profit above Wall Street estimates, betting on an improvement in demand for its drug discovery and developme ...
Analog Devices sees strong second-quarter as AI boom fuels chip sales
Reuters· 2026-02-18 12:49
Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Analog Devices sees strong second-quarter as AI boom fuels chip sales February 18, 202612:49 PM UTCUpdated ago By Reuters An Analog Devices logo appears in this illustration taken August 18, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab Feb 18 (Reuters) - Analog Devices (ADI.O), opens new tab On Wednesday, forecast second-quarter results above Wall Street estim ...
UBS lifts forecast for big tech bond sales this year
Reuters· 2026-02-18 12:47
UBS lifts forecast for big tech bond sales this year | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A logo of Swiss bank UBS is seen in Zurich, Switzerland, May 1, 2025. REUTERS/Denis Balibouse/File Photo [Purchase Licensing Rights, opens new tab]- Companies- Summary- UBS sees companies tapping more non-dollar markets- US leveraged loans forecast to drop- US investment grade bond issuance seen at $360 billionLONDON, Feb 18 (Reuter ...
Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial
Reuters· 2026-02-18 12:13
A two-in-one mRNA vaccine developed by Moderna that targets seasonal influenza and COVID-19 produced robust and durable immune responses without safety concerns in a small mid-stage trial, the company... ...
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal
Reuters· 2026-02-18 12:09
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Cencora Inc]FollowFeb 18 (Reuters) - Drug distributor Cencora [(COR.N), opens new tab] will merge its MWI Animal Health with privately held Covetrus in a deal valuing the unit at $3.5 billion, the companies said on Wednesday, creating a combined animal-health distribution and technology company.Under ...
US FDA to initiate review of Moderna's influenza vaccine
Reuters· 2026-02-18 12:07
Core Viewpoint - The U.S. Food and Drug Administration has accepted Moderna's application to review its influenza vaccine candidate [1] Company Summary - Moderna is advancing its influenza vaccine candidate through the regulatory process with the FDA's acceptance of its application [1]
Uber to invest over $100 million in autonomous vehicle charging amid robotaxi push
Reuters· 2026-02-18 12:01
Uber Technologies said on Wednesday it would invest more than $100 million to develop autonomous vehicle charging hubs, underscoring the ride-hailing company's latest push to scale up self-driving ope... ...
HF Sinclair beats fourth-quarter profit estimates on strong refining margins
Reuters· 2026-02-18 11:36
HF Sinclair beats profit estimates, says CEO to take voluntary leave | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]HF Sinclair Corp logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration [Purchase Licensing Rights, opens new tab]- Companies[HF Sinclair Corp]FollowFeb 18 (Reuters) - HF Sinclair [(DINO.N), opens new tab] topped Wall Street estimates for fourth-quarter profit on Wednesday, ...